InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Ruff Shamim, Director. Officer active across 1 companies, notably Reata Pharmaceuticals INC. Aggregated, 3 reports have been recorded. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€39,6321,222 shares@ €32.432587.5% of flow
Class A common stock
SEC:0001209191-22-035423:0·
€2,834118 shares@ €24.0208100.0% of flow
Class A common stock
SEC:0001209191-22-001627·
€2,834118 shares@ €24.02086.3% of flow
Class A common stock
SEC:0001209191-22-001627:0·
3 of 3 declarations
About Ruff Shamim
Ruff Shamim is a Board Member at Reata Pharmaceuticals Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of the firm. His experience and expertise are essential in guiding Reata Pharmaceuticals within the pharmaceutical sector.
